Orlando, FL 3/19/12 (StreetBeat) -- We wanted to take a moment and give you a reminder to check-out this company. ALR Technologies, Inc. (OTCBB:ALRT) is a healthcare company that is focused on disease management that trades for around a dime a share. The company is not one that runs around touting themselves; in fact, they keep things very low-key. This is presumably because they are meeting with the government (they have referenced “policymakers” in their press releases and moved their headquarters to outside of Washington, D.C.) and are not looking to ruffle the feathers of anyone who could come in a lobby against them. But…last week they announced that they are hosting an investors meeting that will take place today after the closing bell at 4:30 PM EDT. The company will be discussing their developments and their technology, which should give a glimpse at all that they have been working to achieve as their product (Health-e-Connect system) is nearing its official launch. If they’re starting to open the doors to give insight to their plans, this could mean that things have gone very well in their efforts and meetings! A few facts about ALRT is well-positioned to grow quickly in value:
· The company’s flagship product, Health-e-Connect, has FDA 510(k) marketing clearance (something virtually no one else has in the diabetes management space)
· In addition to having FDA clearance, Health-e-Connect (HeC) outstrips any of its limited number of competitors because it is less expensive and doesn’t rely on manual patient input
· Based on government audits of waste and abuse in diabetes supplies, HeC could potentially save the government a quarter of a BILLION dollars annually.
· Clinical trials have shown that technologies like as HeC help lower a1C, the gold standard measurement for controlling the effects of diabetes.
· The company is looking to capitalize by providing a solution for the high costs associated with diabetes management, the most costly chronic disease in the U.S. (10% of the U.S. population has diabetes with that number expected to grow to 33% in the next two decades).
· The company is well-funded. CEO Sidney Chan has put millions of his own dollars into the company.
You don’t have to believe us, check it out yourself! We encourage our members to register for today’s webinar (link below) to see why ALR Technologies is uniquely positioned in the diabetes management space. Seating is limited and we are told that there are only a few left, so don’t hesitate.
https://www4.gotomeeting.com/register/833498439
StreetBeat Disclaimer
No comments:
Post a Comment